Lv5
950 积分 2025-12-17 加入
Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics
14天前
已完结
Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer
2个月前
已关闭
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
2个月前
已完结
Metastatic sites and survival in lung cancer
2个月前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2个月前
已完结
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
2个月前
已完结
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
2个月前
已完结
Comprehensive genomic profiles of small cell lung cancer
2个月前
已完结
Residential radon and small cell lung cancer. A systematic review
2个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
3个月前
已完结
皖公网安备34019202002308
